Snijders Blok–Campeau syndrome
Snijders Blok–Campeau syndrome is a rare genetic disorder characterized by a range of physical and developmental abnormalities. It was first described by the Dutch geneticist Lisenka E. L. Snijders Blok and the Canadian geneticist Philippe M. Campeau in 2018.
Symptoms and Signs[edit | edit source]
The syndrome is characterized by a variety of symptoms, including intellectual disability, speech delay, motor delay, and distinctive facial features. Other symptoms may include hypotonia (low muscle tone), microcephaly (small head size), and epilepsy. The severity and combination of symptoms can vary greatly among individuals with the syndrome.
Genetics[edit | edit source]
Snijders Blok–Campeau syndrome is caused by mutations in the CHD3 gene. This gene provides instructions for making a protein that is involved in chromatin remodeling, a process that helps control the activity of genes. Mutations in the CHD3 gene disrupt this process, leading to the symptoms of the syndrome.
Diagnosis[edit | edit source]
Diagnosis of Snijders Blok–Campeau syndrome is based on clinical features and confirmed by genetic testing to identify a mutation in the CHD3 gene.
Treatment[edit | edit source]
There is currently no cure for Snijders Blok–Campeau syndrome. Treatment is symptomatic and supportive, and may include physical therapy, speech therapy, and occupational therapy. Medications may be used to manage symptoms such as epilepsy.
Prognosis[edit | edit source]
The prognosis for individuals with Snijders Blok–Campeau syndrome varies depending on the severity of symptoms. With appropriate support and treatment, many individuals with the syndrome can lead fulfilling lives.
See Also[edit | edit source]
References[edit | edit source]
- Snijders Blok L, Rousseau J, Twist J, et al. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun. 2018;9(1):4619. doi:10.1038/s41467-018-06014-6
- Campeau PM, Kasperaviciute D, Lu JT, et al. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol. 2014;13(1):44-58. doi:10.1016/S1474-4422(13)70265-5
Snijders Blok–Campeau syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD